All posts in
Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease
The Patent Office has Spoken: What does it Mean for CRISPR in Europe?
The UK Steps Up its Game in Automated CRISPR Gene Editing
Our Startup Battle Winner uses CRISPR in a Whole New Way
UPDATE: No Clear Winner in the CRISPR Patent Battle
Evotec gets hold of CRISPR in a new Partnership with Merck
CRISPR meets RNAi: a whole new Targeted Therapy
CRISPR Thx’ surprisingly low IPO… why are Investors Discouraged?
The CRISPR Revolution is here, but how can we make it Useful?
Promising Boston-based CRISPR Startup hits up Horizon to fix Gene Misregulation
Labiotech UG, All Rights Reserved -
Send this to friend